- New subsidiary will leverage existing US and EU manufacturing capacity, high-purity fluid expertise, and analytical technologies to target liquid cooling performance and reliability in AI and high-performance computing environments

- Data center liquid cooling market is projected to grow from $4 billion in 2026 to $27 billion by 20331

DUBLIN, Ireland and WILSONVILLE, Ore., June 23, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, today announced the launch of Trinovium, a dedicated subsidiary focused on advanced liquid cooling solutions and fluid intelligence systems for next-generation AI data centers. As escalating AI workloads increase compute density and heat generation, driving a rapid industry transition from air cooling to liquid-cooled infrastructure, Trinovium will leverage Trinity's expertise in ultra-high-purity fluid manufacturing, analytical technologies, and large-scale production capabilities to address the growing reliability challenges associated with next-generation liquid cooling systems.